Van Leeuwen & Company, LLC Amgen Inc Transaction History

Van Leeuwen & Company, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 31, 2019	SELL	$166.7 - $195.41 $1.66 Million - $1.94 Million	-9,938 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $2.15 Million - $2.42 Million	-11,871 Reduced 54.43%	9,938 $1.89 Million
Q4 2018 Mar 13, 2019	SELL	$178.4 - $208.25 $18,732 - $21,866	-105 Reduced 0.48%	21,809 $4.25 Million
Q3 2018 Mar 13, 2019	BUY	$185.29 - $208.89 $4.06 Million - $4.58 Million	21,914 New	21,914 $4.54 Million

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Van Leeuwen & Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Van Leeuwen & Company, LLC with notifications on news.